A
ACRS
Aclaris Therapeutics Inc
4.520
-0.020-0.44%After Hours: 4.520 0.000 0.00%18:25 05/22 EDT
OPEN/PREV CLOSE4.540/4.540
TODAY RANGE4.495-4.600
VOL627.71K
MARKET CAP631.28M
52 WEEK RANGE1.220-5.15
AVG VOL (3M)1.84M
% TURNOVER0.45%
TURNOVER--
P/E (TTM)-8.0657
% RANGE2.31%
EPS(TTM)-0.5604
P/E(FORWARD)-6.9538
P/B4.394
BVPS1.029
DIVIDEND--
P/S69.65
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP594.91M
SHARES OUTSTANDING139.66M
NEXT EARNINGS08/05-08/10
FREE FLOAT131.62M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·05/11 11:55
Aclaris Therapeutics (ACRS) Gets a Buy from Piper Sandler
TipRanks·05/11 11:52
Guggenheim Keeps Their Buy Rating on Aclaris Therapeutics (ACRS)
TipRanks·05/08 12:59
Aclaris Therapeutics (ACRS) Gets a Buy from Oppenheimer
Simply Wall St·05/08 06:31
Aclaris Therapeutics (ACRS) Quarterly Loss Near US$20 Million Reinforces Bearish Earnings Narrative
TipRanks·05/07 13:55
Aclaris Therapeutics (ACRS) Gets a Buy from Craig-Hallum
TipRanks·05/07 13:36
Aclaris Therapeutics reports Q1 EPS (15c), consensus (16c)
Benzinga·05/07 13:23
Aclaris Therapeutics Q1 EPS $(0.15), Inline, Sales $1.996M Beat $1.322M Estimate
Reuters·05/07 11:06
Aclaris Therapeutics Q1 net loss widens on higher R&D spending
Seeking Alpha·05/07 11:01
Aclaris Therapeutics GAAP EPS of -$0.15 beats by $0.01, revenue of $2M beats by $0.68M
Dow Jones·05/07 10:59
*Aclaris Therapeutics 1Q Rev $2M >ACRS